SCHEMBL4711518

SCHEMBL4711518

CCNC(=O)[CH]N1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.44
OPRD1 P41143 1/20 0.40
HTT P42858 1/20 0.38
MEN1 O00255 1/20 0.36
SIGMAR1 Q99720 3/20 0.36
CHRM5 P08912 1/20 0.35
CHRM3 P20309 1/20 0.35
GNAI3 P08754 1/20 0.35
GNAO1 P09471 1/20 0.35
GNAI1 P63096 1/20 0.35
CA2 P00918 2/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
CHKA P35790 1/20 0.31
MCL1 Q07820 1/20 0.31
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5112831 0.84 KMT2A (0.45) KMT2AHTTMEN1MCL1
SCHEMBL1820781 0.79 CA2 (0.34) KMT2AMEN1SIGMAR1CHRM5CHRM3
SCHEMBL4744923 0.78 HTT (0.55) KMT2AHTTMEN1
Methylpiperazine SCHEMBL27627001 0.74 KMT2A (0.40) KMT2AOPRD1HTTMEN1SIGMAR1
SCHEMBL962662 0.72 KMT2A (0.75) KMT2AOPRD1HTTSIGMAR1CA2
SCHEMBL1706425 0.71 CA2 (0.38) KMT2AOPRD1MEN1SIGMAR1CHRM5
Hydrochloric Acid SCHEMBL3852849 0.71 KMT2A (0.72) KMT2AOPRD1HTTMEN1SIGMAR1
SCHEMBL3600027 0.71 MEN1 (0.39) KMT2AOPRD1HTTMEN1SIGMAR1
SCHEMBL3590883 0.70 HCAR2 (0.38) KMT2AHTTMEN1SIGMAR1CA2
SCHEMBL4523072 0.68 CHRM5 (0.39) KMT2AOPRD1MEN1SIGMAR1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963331-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS Exelixis, Inc. (US) 2008-09-03 EP disclosed
WO-2007070796-A1 AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS EXELIXIS, INC. (US) 2007-06-21 WO disclosed